lumateperone 10.5 MG Oral Capsule [Caplyta]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
lumateperone 10.5 MG Oral Capsule [Caplyta]
10.5 MG · Oral Capsule · oral
A form of lumateperone →
lumateperone 10.5 MG Oral Capsule [Caplyta] — Butyrophenone derivatives. Strength, form, class, interactions & more.
![lumateperone 10.5 MG Oral Capsule [Caplyta]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=db730b06-6351-47fd-8183-e61e61bbead5&name=caplyta-1.jpg)
Active ingredient
Classification
Butyrophenone derivativesAtypical Antipsychotic
Drug interactions
Lumateperone has clinically important interactions with CYP3A4 inducers and inhibitors, as well as serotonin reuptake inhibitors.
- majorCYP3A4 inducers — decreases the exposure of lumateperone
- moderatestrong CYP3A4 inhibitors — increases lumateperone exposure
- moderatemoderate CYP3A4 inhibitors — increases lumateperone exposure
- moderateserotonin reuptake inhibitors — increased risk of SRI-associated adverse reactions
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication